tgAAV-CFTR

N/A

Report date: 2022/11/25 17:16:40

Base Information

Drug NametgAAV-CFTR
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator inhibitors
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTargeted Genetics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTargeted Genetics Corp
Active IndicationsN/A
Inactive IndicationsCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A